XML 42 R32.htm IDEA: XBRL DOCUMENT v3.23.2
Stock-Based Compensation - Stock Options and Significant Valuation Assumptions (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
May 12, 2022
Jul. 01, 2023
Jun. 25, 2022
Employee Stock Option [Member]      
Stock Options      
Outstanding at the beginning of period   739,480  
Granted   0  
Exercised   (27,219)  
Outstanding at the end of period   712,261  
Vested and expected to vest after end of period   712,261  
Exercisable at end of period   549,564  
Grant Date Weighted-Average Exercise Price      
Outstanding at the beginning of period   $ 31.60  
Exercise price (in dollars per share)   12.68  
Outstanding at the end of period   32.32  
Vested and expected to vest at end of period   32.32  
Exercisable at end of period   $ 25.12  
Weighted Average Remaining Contractual Life      
Weighted average remaining contractual life, awards outstanding   5 years 8 months 12 days  
Weighted average remaining contractual life, awards vested and expected to vest   5 years 8 months 12 days  
Weighted average remaining contractual life, awards exercisable   5 years 1 month 6 days  
Aggregate Intrinsic Value      
Aggregate intrinsic value, awards exercised   $ 1,532  
Aggregate intrinsic value, awards outstanding   37,498  
Aggregate intrinsic value, awards vested and expected to vest   37,498  
Aggregate intrinsic value, awards exercisable   $ 32,740  
CEO | 2020 Plan      
Assumptions used      
Stock price (in dollars per share) $ 86.96    
Exercise price (in dollars per share) $ 86.96   $ 86.96
Expected option term 6 years 6 months    
Expected volatility factor 65.90%    
Risk-free interest rate 2.80%    
Expected annual dividend yield 0.00%    
Stock Options      
Granted     86,189